0 التعليقات
0 المشاركات
409 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Congestive Heart Failure Drugs Market Future Scope, Competitive Landscape and Comprehensive Forecast to 2033Congestive Heart Failure Drugs Industry Outlook: Straits Research has added a report titled “Global Congestive Heart Failure Drugs Market Professional Report 2025-2033” to its database of research reports. The study provides complete details about the usage and adoption of Congestive Heart Failure Drugs in various industrial applications and geographies. This helps the key...0 التعليقات 0 المشاركات 566 مشاهدة 0 معاينة
-
Heart Failure Drugs Market Research Report: Size, Trends, Growth and Forecast 2026–2036NEWARK, Del., Aug. 20, 2026 — The global Heart Failure Drugs Market is expanding as healthcare providers increasingly adopt guideline-directed medical therapy and earlier pharmacological intervention for patients with heart failure. According to Future Market Insights (FMI), the market is projected to grow from USD 18.8 billion in 2026 to USD 37.0 billion by 2036, registering a 7.0% CAGR...0 التعليقات 0 المشاركات 356 مشاهدة 0 معاينة
-
How Rising Heart Failure Prevalence and Novel Therapeutics Are Driving the US Heart Failure Drugs MarketThe US Heart Failure Drugs market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of heart failure and improve patient outcomes. The market was valued at USD 6.14 billion in 2024 and is projected to reach USD 8.14 billion by 2035, growing at a CAGR of 2.6%. The US Heart Failure...0 التعليقات 0 المشاركات 257 مشاهدة 0 معاينة
-
Dobutamine Market Growing at 5.8% CAGR Through 2034According to a new report from Intel Market Research, the global Dobutamine market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.12 billion in 2026 to USD 1.75 billion by 2034, exhibiting a robust CAGR of 5.8% during the forecast period (2026–2034). This growth is propelled by the rising global prevalence of cardiovascular diseases, the expanding aging...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة